Immunotherapy may play role in treating nonmetastatic gastroesophageal cancer
ROCHESTER, Minn. — Immunotherapy has transformed treatment for patients with stage 4 metastatic esophageal and gastric cancers. In patients with these malignancies, immunotherapy has been shown to prolong survival when patients' tumors exhibit a high expression of an immune-related protein called PD-L1. Researcher s are now investigating whether immunotherapy benefits patients who do not have stage 4 metastatic disease. In these patients, tumors have not spread to distant organs. A study highlighting this research is published… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - May 16, 2022 Category: Databases & Libraries Source Type: news
Car T-cell therapy shows early promise in treating gastric cancers
Chinese researchers say interim trial results suggest approach could be important for those with advanced tumoursAn experimental cancer therapy that infuses designer immune cells into patients has shown early promise in a clinical trial by shrinking tumours in the digestive system.Interim results from the first phase of the clinical trial found that the tumours in nearly half – 48.6% – of the 37 patients treated so far reduced in size after the therapy.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - May 9, 2022 Category: Science Authors: Ian Sample Science editor Tags: Cancer research Science Health China UK news Medical research World news Source Type: news
Mayo Clinic Minute: Why early treatment of esophageal cancer is critical
Esophageal cancer, which is cancer that occurs in the esophagus — a long, hollow tube that runs from your throat to your stomach — is on the rise in the U.S. "We think esophageal cancer is on the rise with the obesity pandemic as well as with the problem with the increase in reflux in the United States," says Dr. Shanda Blackmon, a Mayo Clinic thoracic surge on.In this Mayo Clinic Minute, Dr. Blackmon will discuss… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 27, 2022 Category: Databases & Libraries Source Type: news
APOA2 May Serve as a New Biomarker for Gastric Cancer APOA2 May Serve as a New Biomarker for Gastric Cancer
APOA2 is over-expressed in gastric cancer tumor samples and may affect overall survival for patients. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 25, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good sales growth in the first quarter of 2022
Basel, 25 April 2022Group sales increase 11%1 at constant exchange rates (CER) and 10% in Swiss francsPharmaceuticals Divisionsales up 6%; continued strong sales of new medicines for severe diseases. Impact of biosimilars decreases as expected.Diagnostics Divisionsales grow 24% due to good momentum in base business and continued high demand for COVID-19 tests. After a strong first quarter, significant decline in COVID-19-related testing expected.Highlights in the first quarter:FDA approval of Vabysmo (severe eye diseases); CHMP recommends EU approval of Polivy combination (aggressive form of blood cancer), Tecentriq (early...
Source: Roche Media News - April 25, 2022 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good sales growth in the first quarter of 2022
Group sales increase 11%1 at constant exchange rates (CER) and 10% in Swiss francsPharmaceuticals Divisionsales up 6%; continued strong sales of new medicines for severe diseases. Impact of biosimilars decreases as expected.Diagnostics Divisionsales grow 24% due to good momentum in base business and continued high demand for COVID-19 tests. After a strong first quarter, significant decline in COVID-19-related testing expected.Highlights in the first quarter:FDA approval of Vabysmo (severe eye diseases); CHMP recommends EU approval of Polivy combination (aggressive form of blood cancer), Tecentriq (early-stage non-small cel...
Source: Roche Investor Update - April 25, 2022 Category: Pharmaceuticals Source Type: news
Peritoneal Mesothelioma HIPEC Program Comes to Alabama
Patients in Alabama diagnosed with peritoneal mesothelioma cancer no longer need to leave the state in pursuit of optimal care and long-term survival. The best possible mesothelioma treatment is now closer to home.
The O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham recently launched a complex treatment program for several abdominal malignancies that combines extensive cytoreductive surgery with hyperthermic intraperitoneal chemotherapy, also known as HIPEC.
This combination, used only at select specialty centers throughout the U.S., has been especially effective for peritoneal mesothe...
Source: Asbestos and Mesothelioma News - April 21, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Treatment Source Type: news
New Cancer Diet Studies Confirm Effects of Veggies and Red Meat New Cancer Diet Studies Confirm Effects of Veggies and Red Meat
A high consumption of vegetables appears to lower the risk of liver cancer/liver disease, while a high consumption of red meat, organ meats, and processed meats boosts the risk of gastric cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 19, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
B12 deficiency symptoms: Signs the deficiency is paving the way to stomach cancer
VITAMIN B12 deficiency is widely associated with nutritional insufficiencies, but the majority of cases are driven by an ability to absorb the nutrient. Left untreated, the condition can pave the way to severe ill-health. According to various platforms, adverse health outcomes may include stomach cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - April 17, 2022 Category: Consumer Health News Source Type: news
Drug that 'adds years' onto the lives of bladder cancer sufferers will be offered on the NHS
Bladder cancer sufferer Andrew Younger, 72, joined a trial for avelumab after being told that tumours had spread to his lung, neck and stomach, and that he might not live to see the next year. (Source: the Mail online | Health)
Source: the Mail online | Health - April 16, 2022 Category: Consumer Health News Source Type: news
Anti-CD39 Combination Therapy Promising in Gastric/GEJ Cancer
(MedPage Today) -- NEW ORLEANS -- More than 60% of patients with unresectable gastric/gastroesophageal junction (GEJ) cancer responded to the combination of a CD39 inhibitor and chemoimmunotherapy, a small clinical trial showed.
The data showed... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 14, 2022 Category: Hematology Source Type: news
Lymph Node Ratio Helpful for Adjuvant-Chemo Planning in Gastric Cancer Lymph Node Ratio Helpful for Adjuvant-Chemo Planning in Gastric Cancer
In patients with locally advanced gastric cancer, the lymph node ratio has value in determining which patients benefit from adjuvant chemotherapy, a new study suggests.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - April 13, 2022 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news
Mother battling cancer 'scolded by NHS bosses' after she complained about treatment
Harriet Wilson, 34, from London, was diagnosed with bowel cancer in May 2021 and was told the disease would likely kill her. Tumours have since spread to her stomach and ovaries. (Source: the Mail online | Health)
Source: the Mail online | Health - April 7, 2022 Category: Consumer Health News Source Type: news
PET/CT can reduce mediastinal cancer biopsies
PET/CT scans can help prevent the use of invasive biopsies in patients wit...Read more on AuntMinnie.comRelated Reading:
PET visualizes early atherosclerosis
PET/CT predicts treatment outcomes in myeloma patients
PET/CT proves value diagnosing fevers of unknown origin
FAPI-PET may improve diagnosis of gastric cancer
Ga-68 radiotracer outperforms F-18 FDG in lung cancer staging (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 5, 2022 Category: Radiology Source Type: news
Bowel cancer: Lesser known symptoms include stomach pain and fatigue - other signs
BOWEL cancer can have a number of symptoms. Indeed, a doctor has outlined seven signs to look out for. (Source: Daily Express - Health)
Source: Daily Express - Health - April 2, 2022 Category: Consumer Health News Source Type: news
